학술논문

Artemisia alleviates AGE-induced liver complications via MAPK and RAGE signaling pathways modulation: a combinatorial study
Document Type
Academic Journal
Source
Molecular and Cellular Biochemistry. October, 2022, Vol. 477 Issue 10, p2345, 13 p.
Subject
Diabetes therapy
Biological products
Polyphenols
Metabolites
Nitric oxide
Isoflavones
Liver diseases -- Care and treatment -- Complications and side effects
Language
English
ISSN
0300-8177
Abstract
Artemisia herba-alba (AHA) is a traditionally used plant to treat various diseases, including diabetes and metabolic dysfunctions. Plant extracts are generally explored empirically without a deeper assessment of their mechanism of action. Here, we describe a combinatorial study of biochemical, molecular, and bioinformatic (metabolite-protein pharmacology network) analyses to elucidate the mechanism of action of AHA and shed light on its multilevel effects in the treatment of diabetes-related advanced glycation end-products (AGE)-induced liver damages. The extract's polyphenols and flavonoids content were measured and then identified via LC-Q-TOF-MS/MS. Active compounds were used to generate a metabolite-target interaction network via Swiss Target Prediction and other databases. The extract was tested for its antiglycation and aggregation properties. Next, THLE-2 liver cells were challenged with AGEs, and the mechanistic markers were measured [TNF-[alpha], IL-6, nitric oxide, total antioxidant capacity, lipid peroxidation (LPO), and caspase 3]. Metabolite and network screening showed the involvement of AHA in diabetes, glycation, liver diseases, aging, and apoptosis. Experimental confirmation showed that AHA inhibited protein modification and AGE formation. Additionally, AHA reduced inflammatory mediators (IL-6, TNF[alpha]), oxidative stress markers (NO, LPO), and apoptosis (Caspase 3). On the other hand, cellular total antioxidant capacity was restored to normal levels. The combinatorial study showed that AHA regulates AGE-induced liver damages through MAPK-AKT and AGE-RAGE signaling pathways. This report highlights the combination of experimental and network pharmacology for the exact elucidation of AHA mechanism of action as a multitarget option in the therapy of diabetes and AGEs-related diseases.
Author(s): Hichem Moulahoum [sup.1], Faezeh Ghorbanizamani [sup.1], Zineb Khiari [sup.2] [sup.3], Mohamed Toumi [sup.4], Yasmina Benazzoug [sup.3], Kerem Tok [sup.1], Suna Timur [sup.1] [sup.5], Figen Zihnioglu [sup.1] Author Affiliations: (1) [...]